Natco Pharma Limited (NATCOPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.138x

Based on the latest financial reports, Natco Pharma Limited (NATCOPHARM) has a cash flow conversion efficiency ratio of 0.138x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs11.91 Billion ≈ $128.76 Million USD) by net assets (Rs86.54 Billion ≈ $935.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Natco Pharma Limited to measure how many days the company can operate on defensive assets alone.

Natco Pharma Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Natco Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Natco Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Natco Pharma Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Generate Biomedicines, Inc. Common Stock
NASDAQ:GENB
-0.156x
Faraday Technology Corp
TW:3035
-0.038x
Taiwan Secom Co Ltd
TW:9917
0.107x
Sonida Senior Living Inc
NYSE:SNDA
-0.007x
Petrovietnam Power Corp
VN:POW
-0.080x
Sichuan Furong Technology Co Ltd
SHG:603327
-0.013x
Guizhou Panjiang Refined Coal Co Ltd
SHG:600395
0.025x
Kinpo Electronics Inc
TW:2312
-0.025x

Annual Cash Flow Conversion Efficiency for Natco Pharma Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Natco Pharma Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see NATCOPHARM market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs76.12 Billion
≈ $823.24 Million
Rs16.97 Billion
≈ $183.50 Million
0.223x +4.18%
2024-03-31 Rs58.53 Billion
≈ $632.99 Million
Rs12.52 Billion
≈ $135.43 Million
0.214x +130.24%
2023-03-31 Rs91.37 Billion
≈ $988.18 Million
Rs8.49 Billion
≈ $91.83 Million
0.093x +752.04%
2022-03-31 Rs42.64 Billion
≈ $461.09 Million
Rs465.00 Million
≈ $5.03 Million
0.011x -84.95%
2021-03-31 Rs41.23 Billion
≈ $445.93 Million
Rs2.99 Billion
≈ $32.31 Million
0.072x -34.28%
2020-03-31 Rs37.85 Billion
≈ $409.30 Million
Rs4.17 Billion
≈ $45.13 Million
0.110x -42.45%
2019-03-31 Rs34.91 Billion
≈ $377.54 Million
Rs6.69 Billion
≈ $72.33 Million
0.192x +27.11%
2018-03-31 Rs30.76 Billion
≈ $332.66 Million
Rs4.64 Billion
≈ $50.14 Million
0.151x -27.94%
2017-03-31 Rs16.53 Billion
≈ $178.81 Million
Rs3.46 Billion
≈ $37.40 Million
0.209x +166.23%
2016-03-31 Rs13.03 Billion
≈ $140.94 Million
Rs1.02 Billion
≈ $11.07 Million
0.079x -27.85%
2015-03-31 Rs8.51 Billion
≈ $92.04 Million
Rs926.66 Million
≈ $10.02 Million
0.109x -44.61%
2014-03-31 Rs7.33 Billion
≈ $79.24 Million
Rs1.44 Billion
≈ $15.58 Million
0.197x +74.77%
2013-03-31 Rs5.44 Billion
≈ $58.84 Million
Rs611.95 Million
≈ $6.62 Million
0.112x -18.24%
2012-03-31 Rs4.72 Billion
≈ $51.05 Million
Rs649.41 Million
≈ $7.02 Million
0.138x -28.06%
2011-03-31 Rs3.53 Billion
≈ $38.23 Million
Rs675.97 Million
≈ $7.31 Million
0.191x -23.21%
2010-03-31 Rs3.11 Billion
≈ $33.60 Million
Rs773.69 Million
≈ $8.37 Million
0.249x +77.24%
2009-03-31 Rs2.66 Billion
≈ $28.77 Million
Rs373.85 Million
≈ $4.04 Million
0.141x -34.64%
2008-03-31 Rs2.25 Billion
≈ $24.34 Million
Rs483.90 Million
≈ $5.23 Million
0.215x -11.13%
2007-03-31 Rs1.86 Billion
≈ $20.12 Million
Rs450.03 Million
≈ $4.87 Million
0.242x +19.35%
2006-03-31 Rs1.54 Billion
≈ $16.64 Million
Rs311.81 Million
≈ $3.37 Million
0.203x -52.96%
2005-03-31 Rs1.14 Billion
≈ $12.29 Million
Rs489.69 Million
≈ $5.30 Million
0.431x --

About Natco Pharma Limited

NSE:NATCOPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$1.65 Billion
Rs152.51 Billion INR
Market Cap Rank
#7001 Global
#319 in India
Share Price
Rs851.50
Change (1 day)
+0.46%
52-Week Range
Rs792.95 - Rs1206.00
All Time High
Rs1591.09
About

NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; a… Read more